Table 1.
Patient demographics.
Diagnosis | Age | Gender | Disease duration (years) | PsA | PASI | Current systemic treatment |
---|---|---|---|---|---|---|
Plaque psoriasis | 48 | Female | 42 | Yes | Minimal disease activity | Secukinumab |
Plaque psoriasis | 38 | Male | 10 | No | 14.4 | None |
Plaque psoriasis | 43 | Female | Unknown | No | Minimal disease activity | Ustekinumab |
Plaque psoriasis | 55 | Male | 10 | No | Minimal disease activity | None |
Plaque psoriasis | 41 | Male | 10 | Yes | Minimal disease activity | Adalimumab |
Plaque psoriasis | 24 | Female | 13 | No | 5.1 | None |
Plaque psoriasis | 52 | Male | 13 | No | 6 | Ustekinumab |
Plaque psoriasis | 48 | Male | 10 | No | 8.1 | None |
Plaque psoriasis | 29 | Female | 22 | No | 7.7 | None |
Plaque psoriasis | 41 | Female | 28 | Yes | 1.2 | Ustekinumab |
Plaque psoriasis | 35 | Male | 15 | No | 4 | Ustekinumab |
Plaque psoriasis | 37 | Male | 10 | No | 8 | None |
Plaque psoriasis | 48 | Female | 30 | Yes | 13 | None |
Pustular palmoplantar and plaque psoriasis | 70 | Female | Unknown | No | Minimal disease activity | Ustekinumab |
PsA, psoriatic arthritis; PASI, Psoriasis Area and Severity Index.